These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 1316067

  • 21. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR.
    Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
    [Abstract] [Full Text] [Related]

  • 22. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE, Vorob'ev PA, Dvoretskiĭ LI, Izotova GN, Miagkov AV, Shvyreva GS, Iakovlev SV.
    Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction.
    Stass H, Kubitza D, Halabi A, Delesen H.
    Br J Clin Pharmacol; 2002 Mar; 53(3):232-7. PubMed ID: 11874385
    [Abstract] [Full Text] [Related]

  • 31. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C, Bramer SL, Maroli A, Gambertoglio JG.
    Clin Pharmacokinet; 1997 Mar; 33 Suppl 1():32-8. PubMed ID: 9433654
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB, Johnson RD, Jensen B, Magner D, Marbury T, Talbot GH.
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [Abstract] [Full Text] [Related]

  • 34. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG.
    Am J Med; 1991 Dec 30; 91(6A):162S-165S. PubMed ID: 1662888
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of the newer fluoroquinolones.
    Brouwers JR.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S16-22. PubMed ID: 3325926
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.